ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2016 American Transplant Congress

    Better Never Than Late: Differences in Outcomes and Risk Factors for Early and Late Rejection After Kidney Transplantation.

    A. Liu, N. Sarabu, A. Joshua.

    Medicine, University Hospitals Case Medical Center, Cleveland, OH.

    Background: Late acute rejection (AR) is associated with inferior outcomes relative to early AR after kidney transplantation. We sought to examine the differences in risk…
  • 2016 American Transplant Congress

    Is C3d-fixing Donor Specific HLA Antibody Detection Really Necessary?

    P. Malvezzi,1 M. Villemaire,1 A. Bourdin,2 T. Jouve,1 R. Tetaz,1 B. Janbon,1 N. Terrier,3 D. Masson.2

    1Service de Néphrologie, Grenoble University Hospital, Grenoble, France; 2Laboratoire d'Histocompatibilité, EFS, Grenoble, France; 3Service d'Urologie, Grenoble University Hospital, Grenoble, France.

    Introduction: Chronic antibody–mediated rejection is the main cause of late kidney graft loss. The identification of donor-specific antibodies (DSA) in the serum is one of…
  • 2016 American Transplant Congress

    Implications of Subclinical Borderline Acute Cellular Rejection Detected in Protocol Biopsies on Graft Outcomes.

    Z. Zaky,1 C. Yu,1 N. Elfadawy,2 A. Chiesa-Vottero,1 L. Herlitz,1 S. Flechner,1 E. Poggio.1

    1Glickman Urological and Kidney institute, Cleveland Clinic, Cleveland, OH; 2Internal Medicine, Univ. Hospitals Case Medical Center, Cleveland, OH.

    Background: The effects of subclinical borderline acute cellular rejection (BACR-defined as I1T1 per Banff criteria) detected in protocol biopsies (Bx) on subsequent graft function and…
  • 2016 American Transplant Congress

    Global Kidney Exchange.

    M. Rees,1 T. Dunn,1 S. Rees,1 J. Rogers,1 L. Reece,1 A. Roth,2 C. Kuhr,1 O. Ekwenna,1 D. Fumo,1 K. Krawiec,3 S. Jain,1 C. Marsh,1 M. Tan,1 S. Paloyo.4

    1Alliance for Paired Kidney Donation, Perrysburg; 2Stanford University, Palo Alto; 3Duke University, Durham; 4Philippine General Hospital, Manila, Philippines.

    Introduction: Instead of thinking of the developing world as a place where there are desperate people who will sell their kidneys for money, we propose…
  • 2016 American Transplant Congress

    Regression of Asymptomatic Cardiomyopathy and Clinical Outcome of Renal Transplant Recipients: Long-Term Extension of Two Randomized Controlled Trials.

    E. Paoletti, D. Bellino, L. Marsano, R. Russo, F. Masarino, G. Garibotto.

    Nephrology, Dialysis, and Transplantation, University of Genoa, Genoa, Italy.

    Background Asymptomatic left ventricular hypertrophy (LVH) is highly prevalent and associated with adverse outcome in renal transplant recipients (RTRs). Nonetheless, there are currently no available…
  • 2016 American Transplant Congress

    Resveratrol Effectively Suppress Th17 Associated Allo-Immune Responses by the Modulation of AMPK/mTOR Pathway.

    B. Chung, K. Doh, J.-W. Min, K. Kim, B.-M. Kim, M.-L. Cho, C. Yang.

    Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

    The aim of this study is to investigate the effect of resveratrol on Th17 allo-immune responses under tacrolimus (Tac)-based immune suppression. First, we investigated the…
  • 2016 American Transplant Congress

    Live Kidney Donors Have Significant Out-of-Pocket Costs Associated with Donation.

    J. Moore, J. Leanza, A. Massie, N. Dagher, D. Segev.

    Johns Hopkins School of Medicine, Baltimore.

    While financial barriers to transplantation have been recognized, limited data exists on the total non-reimbursed expense associated with live donation. Furthermore, donor costs have not…
  • 2016 American Transplant Congress

    Recipient Age and KDPI Are Potent Predictors of Early Acute Rejection in the Modern Era of Deceased Donor Kidney Transplantation.

    D. Keith, G. Vranic, A. Nishio Lucar.

    Medicine, University of Virginia, Charlottesville, VA.

    The rate of acute rejection in the first six months after deceased donor (DD) kidney transplant is about 10% in the modern era of immunosuppression.…
  • 2016 American Transplant Congress

    Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.

    D. Zecher,1 A. Cumpelik,2 B. Ruhland,1 B. Banas,1 H. Hopfer,3 M. Dickenmann,4 J. Schifferli.2

    1Nephrology, Regensburg University Hospital, Regensburg, Germany; 2Biomedicine, Basel University Hospital, Basel, Switzerland; 3Pathology, Basel University Hospital, Basel, Switzerland; 4Nephrology, Basel University Hospital, Basel, Switzerland.

    Background: The release of surface-derived microvesicles (MV) is a common phenomenon of cellular activation and occurs specifically as a consequence of terminal complement complex assembly…
  • 2016 American Transplant Congress

    Early Onset Hyperuricemia Is a Prognostic Marker for Kidney Allograft Dysfunction.

    M. Han,1 S. Yang,2 I. Jung,3 S.-K. Park,4 Y. Kim,5 D. Han,5 Y. Kim,1 S. Kim,6 J. Lee.7

    1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; 2Kidney Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; 3Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; 4Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; 5Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; 6Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; 7Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.

    Aim: It is not certain whether hyperuricemia is a true risk factor of kidney allograft failure. We investigated the association of hyperuricemia and graft outcome.Methods:…
  • « Previous Page
  • 1
  • …
  • 433
  • 434
  • 435
  • 436
  • 437
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences